D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Vernova
GEV
|
+$601M |
| 2 |
Walt Disney
DIS
|
+$510M |
| 3 |
Palantir
PLTR
|
+$502M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$490M |
| 5 |
TSMC
TSM
|
+$396M |
Top Sells
| 1 |
Boeing
BA
|
+$967M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 4 |
Eli Lilly
LLY
|
+$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.62% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Paymentus
PAY
$4.41B
| $256K | ﹤0.01% |
9,800
-400
| -4% | -$10.4K |
|
2577
V2X
VVX
$1.73B
| $254K | ﹤0.01% |
5,180
-49,979
| -91% | -$2.45M |
|
2578
National Health Investors
NHI
$3.71B
| $254K | ﹤0.01% |
+3,437
| New | +$254K |
|
2579
Altimmune
ALT
$324M
| $253K | ﹤0.01% |
50,516
-409,317
| -89% | -$2.05M |
|
2580
First Trust Financials AlphaDEX Fund
FXO
$2.23B
| $251K | ﹤0.01% |
4,736
-15,157
| -76% | -$803K |
|
2581
WisdomTree US MidCap Fund
EZM
$818M
| $250K | ﹤0.01% |
4,191
| – | – |
|
2582
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$683M
| $249K | ﹤0.01% |
5,098
-100
| -2% | -$4.89K |
|
2583
Lennar Class B
LEN.B
$33.8B
| $248K | ﹤0.01% |
2,278
-11,008
| -83% | -$1.2M |
|
2584
iShares US Healthcare Providers ETF
IHF
$811M
| $247K | ﹤0.01% |
4,673
-1,300
| -22% | -$68.6K |
|
2585
Graphic Packaging
GPK
$6.14B
| $246K | ﹤0.01% |
9,494
+1,066
| +13% | +$27.7K |
|
|
RUMBW
2586
Rumble Inc. Warrant
RUMBW
$751M
| $245K | ﹤0.01% |
106,572
| – | – |
|
2587
iShares US Consumer Discretionary ETF
IYC
$1.72B
| $244K | ﹤0.01% |
+2,758
| New | +$244K |
|
2588
Bank First Corp
BFC
$1.26B
| $243K | ﹤0.01% |
+2,415
| New | +$243K |
|
2589
Invesco BuyBack Achievers ETF
PKW
$1.47B
| $241K | ﹤0.01% |
2,140
| – | – |
|
2590
Dr. Reddy's Laboratories
RDY
$12.1B
| $240K | ﹤0.01% |
18,210
-411,677
| -96% | -$5.43M |
|
2591
The RMR Group
RMR
$282M
| $240K | ﹤0.01% |
+14,406
| New | +$240K |
|
2592
Northern Oil and Gas
NOG
$2.52B
| $239K | ﹤0.01% |
7,900
-105,054
| -93% | -$3.18M |
|
2593
Cullinan Oncology
CGEM
$382M
| $238K | ﹤0.01% |
31,494
-17,438
| -36% | -$132K |
|
2594
Argan
AGX
$3.12B
| $238K | ﹤0.01% |
1,812
| – | – |
|
2595
California Water Service
CWT
$2.72B
| $237K | ﹤0.01% |
4,895
-32,302
| -87% | -$1.57M |
|
2596
Invesco China Technology ETF
CQQQ
$1.43B
| $236K | ﹤0.01% |
+5,329
| New | +$236K |
|
2597
First Commonwealth Financial
FCF
$1.84B
| $236K | ﹤0.01% |
+15,170
| New | +$236K |
|
2598
Civista Bancshares
CIVB
$407M
| $234K | ﹤0.01% |
11,988
+215
| +2% | +$4.2K |
|
|
ARTY
2599
iShares Future AI & Tech ETF
ARTY
$1.45B
| $234K | ﹤0.01% |
7,428
| – | – |
|
2600
Camden National
CAC
$679M
| $233K | ﹤0.01% |
+5,760
| New | +$233K |
|